Search Results - "Bardelli, Geraldine"

226 Neoantigen-specific TCR-T cells targeting shared hotspot mutations for adoptive cell therapy in common epithelial cancers by Korngold, Ana, Yong, Lin-Kin, Ibekwe, Ugochi, Simmons, Julissa, Eckels, Phillip, Figueroa, Elizabeth, Hotard, Michelle, Adeyemi, Frances, Hunt, Thomas, Markus, Tegan, Hurton, Lenka, Shi, Yaoyao, Collinson-Pautz, Matthew, Balasubramanian, Priya, Wang, Cathy, Andersson, Jourdan, Heese, Lauren, Khalil, Mariam, Torres, David, Olivares, Emarco, Bardelli, Geraldine, O’Brien, Kelly, Hashmi, Haroon, Chekmasova, Alena, Baffa, Raffaele, Spencer, Tom, Groot, Eleanor De, Deniger, Drew

“…Background EGFR, KRAS and TP53 have frequent somatic hotspot mutations giving rise to biologically relevant amino acid substitutions in EGFR, KRAS and p53…”
Get full text

A Phase 1 Dose-Escalation Study of the Oral Epichaperome Inhibitor, Zelavespib (ZEL) in Combination with Ruxolitinib (RUX), in Patients with Relapsed Myelofibrosis: Results of the Dose Escalation Stage by Pemmaraju, Naveen, Gundabolu, Krishna, Snyder, Jack, Silverman, Michael H, Bardelli, Geraldine, Verstovsek, Srdan, Schiller, Gary J.

Get full text

Safety, Tolerability and Pharmacokinetics of Icapamespib, a Selective Epichaperome Inhibitor, in Healthy Adults by Silverman, M. H., Duggan, S., Bardelli, Geraldine, Sadler, B., Key, C., Medlock, M., Reynolds, L., Wallner, B.

“…Background Neurodegenerative diseases are devastating conditions that most commonly affect individuals 65 years and older. Currently there are no effective…”
Get full text